Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Anticandidal Therapeutics: Discovery and Development helps researchers form the basis of discovery and development of novel anticandidal therapies. In 14 chapters, the book provides collective information on anticandidal agents and their discovery and development with respect to major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical study status of anticandidal therapeutic agents, and drug repurposing for the development of novel anticandidals. This book provides readers with comprehensive knowledge on the fungal human infection candida and the development of anticandidal drugs.
Developments of anti-fungal agents have declined as compared to other antibiotics. There is an urgent need for both prophylactic and therapeutic treatments worldwide to control the severity of infections caused by Candida.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Anticandidal Therapeutics: Discovery and Development helps researchers form the basis of discovery and development of novel anticandidal therapies. In 14 chapters, the book provides collective information on anticandidal agents and their discovery and development with respect to major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical study status of anticandidal therapeutic agents, and drug repurposing for the development of novel anticandidals. This book provides readers with comprehensive knowledge on the fungal human infection candida and the development of anticandidal drugs.
Developments of anti-fungal agents have declined as compared to other antibiotics. There is an urgent need for both prophylactic and therapeutic treatments worldwide to control the severity of infections caused by Candida.